The dierent platelet-derived growth factor (PDGF) isoforms cause activation of their a and b protein tyrosine kinase receptors through dimerization. Homodimerization as well as heterodimerization of receptors occur. It has been shown previously that the heterodimeric receptor complex mediates a stronger mitogenic response than either of the homodimeric complexes. In this report, we show that in cells expressing both PDGF a-and b-receptors, stimulation with PDGF-AB, which leads to preferential heterodimer formation, leads to a very low degree of phosphorylation of Tyr771 in the breceptor. In contrast, Tyr771 is phosphorylated in a homodimeric complex of b-receptors. Phosphorylated Tyr771 is a binding site for RasGAP; an analogous site is not present in the a-receptor, which lacks the ability to associate with RasGAP. The lowered phosphorylation of Tyr771 in the heterodimeric receptor complex correlates with lowered association with RasGAP, as well as with a more ecient activation of Ras and MAP kinase, which is consistent with the increased mitogenicity elicited by PDGF-AB, compared to PDGF-AA or PDGF-BB.
Introduction
Receptor tyrosine kinases are often activated by ligandinduced dimerization (reviewed in Heldin, 1995) . This leads to autophosphorylation of tyrosine residues in the intracellular parts of the receptors, which then act as docking sites for down-stream signal transduction molecules containing SH2 or PTB domains (reviewed in Pawson and Scott, 1997) . Since the amino acid sequence around the phosphorylated tyrosine determines the speci®city for binding of individual SH2 and PTB domains, the exact localization of phosphorylated tyrosine residues will determine which signals are induced.
In addition to homodimerization of tyrosine kinase receptors, speci®c heterodimeric receptor complexes of structurally related receptors can also be formed after ligand binding. Examples include heteromeric complexes of members of the epidermal growth factor receptor family Solto et al., 1994; Wada et al., 1989; Heidaran et al., 1991; Kanakaraj et al., 1991; Seifert et al., 1989) . PDGF is a family of dimeric isoforms of related A-and Bpolypeptide chains, which exert their cellular eects by binding to two structurally similar tyrosine kinase receptors. Since the B-chain binds to both a-and breceptors with high anity, whereas the A-chain binds only to a-receptors, the dierent PDGF isoforms induce dierent dimeric receptor complexes; PDGF-AA induces aa receptor dimers, PDGF-AB aa and ab receptor dimers and PDGF-BB all three possible receptor combinations.
Homodimerization of PDGF a-or b-receptors has been shown to lead to autophosphorylation of at least ®ve or ten tyrosine residues, respectively (reviewed in Heldin et al., 1998) which interact in a speci®c manner with several SH2 domain containing signal transduction molecules. Phosphatidylinositol-3'-kinase, phospholipase C-g, and the cytoplasmic tyrosine kinases of the Src family are examples of signal transduction molecules binding to both a-and b-receptors, whereas the GTPase activating protein (GAP) of Ras binds only to b-receptors (Bazenet and Kazlauskas, 1994; Heidaran et al., 1993) and the adaptor molecule Crk only to a-receptors (Yokote et al., 1998) .
Among the PDGF isoforms, PDGF-AB has been reported to have the most potent mitogenic eect on cells expressing both a-and b-receptors (Heidaran et al., 1991; Rupp et al., 1994) . We therefore investigated whether the heterodimeric PDGF receptor complex has unique properties compared to the homomeric receptor complexes. We report that the heteromeric complex gives a stronger and more sustained activation of Ras and Erk2 compared to homodimeric complexes, which may be explained by our ®nding that RasGAP, which deactivates Ras, binds to the bb receptor homodimer, but not to the ab receptor heterodimer. The mechanism behind this dierence appears to involve autophosphorylation of Tyr771, to which RasGAP binds, in the b-receptor in the homodimer, but not in the b-receptor in the heterodimeric complex. cells were investigated. As shown in Figure 1 , PDGF-AB gave a higher incorporation of [ 3 H]thymidine than PDGF-AA or PDGF-BB at concentrations up to 10 ng/ml. The dierences are rather small but reproducible and consistent with previous observations .
PDGF-AB induces more ecient activation of Ras and MAP kinase than other PDGF isoforms
Activation of Ras and subsequent activation of the kinases in the MAP kinase cascade, i.e. Raf-1, MEK and MAP kinase, has been shown to be important for mitogenic stimulation (Cai et al., 1990; Mulcahy et al., 1985) . PDGF-stimulation has been shown to cause activation of Ras via direct or indirect binding of the nucleotide exchange protein Sos1 in complex with the adaptor Grb2 to the PDGF receptors (Arvidsson et al., 1994; Li et al., 1993; Yokote et al., 1994) . We therefore investigated the eciencies of various PDGF isoforms to activate Ras and MAP kinase.
To estimate Ras activation, 32 P-orthophosphate labeled PAE/ab cells were stimulated with dierent PDGF isoforms, followed by immunoprecipitation of Ras; the binding of GTP and GDP to Ras, as markers of active and inactive Ras, respectively, was determined by thin layer chromatography. As seen in Figure 2 , all PDGF isoforms increased the GTP/GDP ratio on Ras, with a maximum after 5 min. PDGF-AB reproducibly gave a slightly higher activation of Ras compared to the other isoforms.
One of the downstream eectors of Ras is Raf-1, the ®rst kinase in the MAP kinase cascade. MAP kinase activity was measured after dierent time periods of stimulation by the dierent PDGF isoforms, using myelin basic protein as a substrate. In this assay, a biphasic response was obtained with an early peak at about 5 min and a later after 60 min; during both these phases PDGF-AB gave higher activation than PDGF-AA or PDGF-BB (Figure 3) .
RasGAP binds to the PDGF b-receptor in a homodimeric but not in a heterodimeric receptor complex RasGAP induces the GTPase activity of Ras and thereby converts active GTP-Ras to inactive GDP-Ras. GAP has been shown to bind to homodimeric breceptor complexes but not to homodimeric a-receptor complexes (Heidaran et al., 1993) . It is thus possible with PDGF-BB (*) for indicated time periods at 378C, followed by lysis of cells and immunoprecipitation with an antiserum against MAP kinase. The immunoprecipitates were subjected to an in vitro kinase assay in the presence of myelin basic protein (MBP) as an exogenous substrate and then analysed by SDS ± PAGE using a 15% polyacrylamide gel. The protein bands corresponding to MBP were quanti®ed using a Fuji BAS 2000 Bioimage Analyzer and plotted relative to control cells, where no ligand was added. The data is a representative one of four experiments that the binding of GAP to the b-receptor counteracts the activation of Ras that is achieved by the binding of the Grb2-Sos complex to the receptor. We investigated whether a dierential interaction between GAP and the PDGF b-receptor could explain the dierences in activation of Ras and MAP kinase by the dierent PDGF isoforms.
GAP immunoprecipitates from PAE/ab cells stimulated with dierent PDGF isoforms were subjected to in vitro kinase assay. A 32 P-labeled component of the same size as the PDGF b-receptor was observed in GAP immunoprecipitates from cells stimulated with PDGF-BB; a faint band of similar size was also seen after stimulation with PDGF-AB, but not after stimulation with PDGF-AA ( Figure 4a ). A similar pattern was also seen when stimulated PAE/ab cells were subjected to immunoprecipitation with a GAP antiserum followed by blotting with phosphotyrosine antibodies; PDGF-BB induced co-precipitation of a component which most likely is the PDGF b-receptor, PDGF-AB had less eect and PDGF-AA was unable to induce co-immunoprecipitation of the receptor with GAP ( Figure 4b ). These data are consistent with a more ecient association of GAP with the b-receptor in a homomeric receptor complex than in a heteromeric receptor complex.
To characterize the type of receptors that are activated in response to the dierent PDGF isoforms, PAE/ab cells were serum-starved overnight and stimulated with 100 ng/ml of PDGF-AA, -AB or -BB. Cells expressing the PDGF b-receptor (PAE/ PDGFRb) alone were stimulated with PDGF-BB as a control. As shown in Figure 4c , PDGF-BB gave a stronger tyrosine phosphorylation of the PDGF breceptor compared to PDGF-AB, which indicates a more ecient activation of homodimeric PDGF breceptor after stimulation with PDGF-BB compared to PDGF-AB.
Lowered phosphorylation of Tyr771 in the b-receptor in a heteromeric receptor complex
A possible explanation for the lower association of GAP with the b-receptor in complex with the areceptor, compared to the homomeric b-receptor could be a lowered phosphorylation of Tyr771, which is the known docking site for GAP in the b-receptor (Fantl et al., 1992; Kazlauskas et al., 1992) . To explore this possibility, PAE/ab cells were labeled with 32 Porthophosphate and then stimulated with PDGF-BB or PDGF-AB for 60 min. PDGF b-receptors were immunoprecipitated and subjected to tryptic digestion. The tryptic digests were then subjected to immunoprecipitation with a peptide antiserum raised against a synthetic peptide corresponding to the sequence of the tryptic peptide containing Tyr771; these immunoprecipitates were then subjected to Edman degradation. As shown in Figure 5 , 32 P-radioactivity was released in cycles 1, 9 and 16 of the peptide from PDGF-BB stimulated cells, corresponding to Tyr763, Tyr771, and Tyr778, indicating that all these tyrosine residues are autophosphorylation sites. No appreciable radioactivity was observed in cycle 13 corresponding to Tyr775. In contrast, when the tryptic peptide from PDGF-ABstimulated cells were subjected to Edman degradation, [ Figure 4 (a) Interaction between RasGAP and the stimulated PDGF b-receptor in homo-and heterodimeric complexes. PAE/ ab cells or PAE/PDGFRb cells were serum-starved overnight and then stimulated with 100 ng/ml of PDGF-AA, -AB or -BB for 1 h at 48C followed by another 5 min at 378C. The cells were lysed and the lysates incubated with antibodies against RasGAP. The immunoprecipitates were then subjected to in vitro kinase assay on beads, followed by SDS ± PAGE and electrotransfer to a PVDF membrane. The membrane was then treated with 1 M KOH at 558C for 1 h, and subjected to autoradiography. (b) Dierential binding of RasGAP to the PDGF-b receptor in homo-and heterodimeric receptor complexes. PAE/ab cells or PAE/PDGFRb cells were serum-starved overnight and then stimulated with 100 ng/ml of PDGF-AA, -AB or -BB for 1 h at 48C, followed by another 5 min at 378C. Cells were lysed and incubated with RasGAP antibodies. The immunoprecipitated samples were separated by SDS ± PAGE using gradient gels of 5 ± 10% polyacrylamide and then electrotransferred to a PVDF membrane. The membrane was immunoblotted with antiphosphotyrosine antibodies. The positions of the PDGF breceptor (bR) and molecular weight markers are indicated to the right and left, respectively of the gels in (a) and (b) of this ®gure, and in Figure 6 . (c) Receptor activation in response to PDGF isoforms. PAE/ab cells or PAE cells expressing only the PDGF b-receptor (PAE/PDGFRb) were serum-starved overnight and then stimulated with 100 ng/ml of PDGF-AA, -AB or -BB for 1 h at 48C followed by another 5 min at 378C. The cells were lysed and the lysates incubated with Wheat Germ Lectin Sepharose. The precipitated samples were separated by SDS ± PAGE using 5 ± 10% polyacrylamide gels and then electrotransferred to a PVDF membrane. Tyrosine phosphorylation was then detected on the membrane using anti-phosphotyrosine antibodies in other cycles, indicating that Tyr763 was phosphorylated but not Tyr771, Tyr775 and Tyr778 of the breceptor in an ab receptor heterodimer.
Increased mitogenic response to PDGF-BB in PAE cells expressing wild type a-receptors and a mutant PDGF b-receptor lacking the RasGAP binding site
In order to further evaluate the importance of Tyr771 in the b-receptor in negative regulation of Ras, PAE cell lines were established stably expressing equal levels of wild type PDGF a-receptors and mutant PDGF breceptors, with Tyr771 replaced with a phenylalanine residue. Three dierent PAE/abY771F clones, with receptor expression levels comparable with PAE/ab cell lines (data not shown), were selected for further studies.
The Y771F mutation in the PDGF b-receptor was analysed in PAE/abY771F cell lines to assess whether this mutation aects the kinase activity of the receptor. PAE/abY771F cells were serum-starved overnight and stimulated with 100 ng/ml PDGF-AA or PDGF-BB for 1 h at 48C. PAE/ab cells and cells expressing only the PDGF a-receptor or the PDGF b-receptor were used as control cell lines. As shown in Figure 6 , the Y771F mutation of the PDGF b-receptor did not aect its kinase activity, since PDGF-BB stimulation gives a similar tyrosine phosphorylation of the PDGF breceptor as in the control cell lines.
The dierent PDGF isoforms were used to stimulate incorporation of [ 3 H]thymidine in PAE/abY771F cells. As shown in Figure 7 , PDGF-BB gave a stronger mitogenic response than PDGF-AA and PDGF-AB. This is to be compared with the mitogenic response in the PAE/ab cell line, where PDGF-AB is the most potent isoform in stimulating [ P-orthophosphate labeling and were then stimulated with 100 ng/ml of PDGF-AB or -BB. Cells were lysed and the lysates were incubated with anti-phosphotyrosine antibodies. The immunoprecipitates were eluted from Protein A-Sepharose beads, treated with iodoacetamide to prevent redimerization and immunoprecipitated again with anti-PDGF b-receptor antibodies. The samples were separated by SDS ± PAGE and electrotransferred to a nitrocellulose ®lter. After tryptic digestion of the receptors, the digests were incubated with antibodies directed against the region of the PDGF b-receptor comprising Tyr771 and the eluted immunoprecipitates were then analysed by Edman degradation by the use of a gas phase sequencer. The release of radioactivity in each cycle is indicated as arbitrary units. The deduced sequence in the PDGF b-receptor is shown with the tryptic cleavage sites indicated by arrows. The upper ®gure is from PDGF-BB stimulated cells and the lower ®gure is from PDGF-AB stimulated cells. The sequence of the immunoprecipitated tryptic sequence is shown. Tryptic cleavage sites are indicated by arrow heads Figure 6 Ligand-stimulated kinase activity of Y771F mutated PDGF b-receptor. PAE/abY771F cells, PAE/ab cells or PAE cells expressing either wild type PDGF a-receptor (PAE/PDGFRa) or PDGF b-receptor (PAE/PDGFRb) alone were serum-starved overnight and then stimulated or not with 100 ng/ml PDGF-AA or PDGF-BB for 1 h at 48C. The cells were lysed and the lysates incubated with Wheat Germ Lectin Sepharose. The precipitated samples were separated by SDS ± PAGE using 5 ± 10% polyacrylamide gels and then electrotransferred to a PVDF membrane. The membrane was immunoblotted with antiphosphotyrosine antibodies lines were established expressing mutant PDGF breceptors with a tyrosine to phenylalanine substitution at position 771. Two dierent PAE/bY771F cell clones, with receptor expression comparable with those of PAE/abY771F cell lines, were selected for further studies.
As shown in Figure 8a , the Y771F mutant PDGF breceptor mediated a signi®cantly stronger mitogenic response compared to the wild type receptor as determined by a [ 3 H]thymidine incorporation assay. This result suggests that a phosphorylated Tyr771 allowing binding of RasGAP in the negative regulation of mitogenicity, and is consistent with the ®nding that PDGF-BB gave a strong mitogenic response in PAE/ abY771 cells (Figure 7) .
In order to investigate the importance of the Y771F mutation for MAP kinase activation, PAE/bY771F cells and PAE/PDGFRb cells were stimulated with PDGF-BB for dierent time periods. MAP kinase activity was then measured using myelin basic protein as a substrate. As shown in Figure 8b , the Y771F mutant PDGF b-receptor mediated a signi®cantly higher activation of MAP kinase after 5 min of PDGF-BB stimulation compared to the wild type receptor. This data indicates the importance of RasGAP in negative regulation of the Ras/MAP kinase pathway and can help to explain the strong eect of PDGF-AB on mitogenicity and Ras/MAP kinase activation observed in PAE/ab cells.
Discussion
PDGF-stimulation leads to an activation of Ras and the MAP kinase cascade, through the binding of the Grb2/Sos1 complex to the autophosphorylated receptor or to components associated with the receptor. The stimulatory signal is, however, modulated by an inhibitory signal exerted by the binding of GAP to the activated receptor, which converts active Ras×GTP to inactive Ras×GDP. The notion that GAP exerts such a negative control function is supported by the ®nding that PDGF-induced Ras activation is increased in cells from mice with the GAP gene inactivated (van der Geer et al., 1997) . Thus the net activation of Ras is determined by the balance between stimulatory and inhibitory signals.
We show in this report that Tyr771 is phosphorylated in a homodimer of PDGF b-receptors, but not in an ab receptor heterodimer. The consequence is that GAP can bind to a homodimeric but not to a heterodimeric receptor complex. The inability of the heterodimeric receptor complex to bind GAP correlates with an increased ability to activate Ras and MAP kinase, and to an increased mitogenic signaling. The notion that GAP binding to receptor complexes exerts a negative control mechanism is further supported by the ®nding that PDGF-BB gives a more potent mitogenic eect than PDGF-AB in cells expressing wild type a-receptors together with a Y771F mutant b-receptor unable to bind GAP, whereas the reverse is true in cells with wild type a-receptors and wild type b-receptors.
The reason why Tyr771 is phosphorylated in a homodimeric bb receptor complex but not in the heterodimeric ab receptor complex is not known. It is possible that the substrate speci®city of the a-and breceptor kinases dier, so that Tyr771 can be recognized as a phosphoacceptor site by the b-receptor but not by the a-receptor. However, when a chimera of the PDGF a-receptor with the PDGF b-receptor kinase insert was assayed for phosphorylation of the tyrosine residue corresponding to Tyr771 in the PDGF b-receptor, the degree of phosphorylation was as in the wild type PDGF b-receptor (data not shown). This suggests that the lack of phosphorylation of Tyr771 in the PDGF b-receptor is not due to the speci®city of the PDGF a-receptor kinase. Alternatively, the a-receptor, but not the b-receptor, recruits and activates a phosphatase which eciently dephosphorylates Tyr771 in the b-receptor. A third possibility is that a hitherto unknown tyrosine kinase associates with the PDGF b-receptor, but not with the PDGF areceptor, and phosphorylates Tyr771.
Our observations provide an illustration that heterodimeric complexes of tyrosine kinase receptors can have dierent properties compared to the corresponding homodimeric complexes, and also provide a molecular mechanism herefore, i.e. differences in autophosphorylation. Analogously, functional dierences between various heterodimeric and homodimeric complexes of members of the EGF receptor family have also been reported (Graus-Porta et al., 1997; Pinkas-Kramarski et al., 1996) . It is possible that the ability to form heterodimeric complexes within structurally related subfamilies is a general property of tyrosine kinase receptors. Whether homo-or heteromeric complexes will be formed depend on the receptor binding speci®city of the stimulating ligand as well as on the level of expression of dierent receptors on the target cell. This provides a mechanism whereby the spectrum of responses can be enlarged using a limited number of receptors.
Materials and methods

Plasmids, cells and cell culture
A cDNA encoding the full-length PDGF a-receptor (Claesson-Welsh et al., 1989) was inserted into the eukaryotic expression vector pcDNA3 (Invitrogen). Another eukaryotic expression vector, pBabe, containing a puromycin resistance gene was used for cotransfection of cells (Morgenstern and Land, 1990) . These two constructs were cotransfected into porcine aortic endothelial (PAE) cells expressing the wild type PDGF b-receptor, using electroporation. Stable transfectants were obtained by selection with puromycin (Calbiochem) at a concentration of 0.5 mg/ml. The PAE cells were maintained as previously described (Mori et al., 1991) . For starvation, subcon¯uent cell cultures were incubated for 16 h in Ham's F-12 medium containing 0.3% fetal bovine serum (FBS, Gibco).
Antibodies and ligands
The peptide antisera PDGFR-3 and PDGFR-7, directed against the carboxyterminal tails of PDGF b-and areceptors, respectively, have been described previously Mori et al., 1993) . The monoclonal anti-phosphotyrosine antibody PY20 was purchased from Transduction Laboratories. Antiserum against p120RasGAP was from Santa Cruz Biotechnology Inc. Peroxidase-conjugated sheep anti-mouse was from Amersham Corp. Rabbit anti-mouse Ig antibody and rabbit anti-rat Ig antibody were from Dakopatts. An antiserum recognizing amino acid residues 771 ± 789 in the human PDGF b-receptor was a kind gift of Dr Thomas O Daniel, Vanderbilt University (Nashville, TN, USA) (Kumjian et al., 1989) . A rabbit antiserum reacting with Erk2 was raised against the carboxyterminal sequence EETARFQP-GYRS (Leevers and Marshall, 1992) . PDGF-AA, PDGF-BB and PDGF-AB were kind gifts from Amgen.
Immunoprecipitation and Western blotting
Cells were starved overnight in Ham's F-12 medium containing 0.3% FBS, preincubated with 100 mM Na 3 VO 4 and then treated with 100 ng/ml PDGF for 1 h at 48C followed by 5 min at 378C. Cells were rinsed twice with icecold phosphate-buered saline (PBS) and lysed in 1% Triton X-100, 10% glycerol, 100 mM NaCl, 20 mM HEPES, pH 7.4, 5 mM EDTA, 1% Trasylol, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 200 mM Na 3 VO 4 , 10 mg/ml leupeptin (Boehringer Mannheim). Lysates were incubated at 48C with 3.5 mg of a-GAP antibody (Santa Cruz) per sample for 2 h, followed by incubation with Protein A-Sepharose 6MB (Pharmacia Biotech) for 30 min at 48C. Lysates were also incubated with 100 ml 1 : 1 slurry of Wheat germ Lectin Sepharose 6 MB (Pharmacia Biotech) for 1.5 h end-over-end at 48C to enrich a glycoprotein fraction. The immunoprecipitates were washed four times with lysis buer and once with 20 mM HEPES, pH 7.4, and then subjected to SDS-polyacrylamide electrophoresis.
For Western blotting, the proteins were electrotransferred from the polyacrylamide gel to a polyvinylidene di¯uoride (PVDF) membrane, which were then blocked with PBS containing 0.2% Tween 20. The blots were then incubated with anti-phosphotyrosine antibody PY20 (1:2000 dilution), washed and incubated with horseradish peroxidase-conjugated sheep anti-mouse immunoglobulins (1:5000 dilution). After washing, the proteins were visualized using the ECL Western blotting detection system (Amersham).
In vitro kinase assay
The in vitro kinase assays were performed essentially according to Hansen et al. (1996) . After treatment with PDGF, the cells were lysed in Triton X-100 lysis buer supplemented with 1 mM dithiothreitol (DTT) and the lysates were then incubated with respective antibody. After Protein A-Sepharose incubation, the samples were subjected to kinase assay and analysed by SDS ± PAGE. The proteins were electrotransferred to a PVDF membrane; the blots were then treated with 1 M KOH at 558C for 1 h according to Kamps and Sefton (1989) to remove background due to serine phosphorylation, and subjected to autoradiography.
In vivo
32 P-orthophosphate labeling
Labeling was performed according to RoÈ nnstrand et al. (1992) , with some modi®cations. Brie¯y, subcon¯uent cells were washed three times with phosphate-free Ham's F-12 medium supplemented with 0.1% dialyzed fetal calf serum and 20 mM HEPES. Cells were then labeled in phosphate-free medium containing 3 mCi/ml 32 P-orthophosphate for 3 h at 378C. Cells were stimulated with 100 ng/ml of PDGF for 1 h at 48C in the same medium, washed in icecold PBS and then lysed in 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 20 mM HEPES pH 7.4, 5 mM EDTA, 30 mM Na 4 P 2 O 7 , 1% Trasylol, 1 mM PMSF, 200 mM Na 3 VO 4 , 10 mg/ml leupeptin. Immunoprecipitation was performed using anti-phosphotyrosine antibody PY20 in the presence of 100 mg of RNaseA and 50 mg of DNaseI (Boehringer Mannheim). After incubation with Protein A-Sepharose, the samples were washed with lysis buer, heated at 958C for 2 min in Tris buered saline (TBS) containing 1% SDS and 10 mM DTT and then incubated with 50 mM of iodoacetamide for 15 min at room temperature. Supernatants were diluted ten times with lysis buer and subjected to immunoprecipitation using antisera against PDGF a-receptor (PDGF-R7) or breceptor (PDGF-R3). The samples were separated by SDS ± PAGE and then electrotransferred to a nitrocellulose membrane (Hybond C-Extra, Amersham). The bands corresponding to the phosphorylated PDGF b-receptor were cut out and subjected to tryptic cleavage.
In situ trypsin digestion and immunoprecipitation after tryptic cleavage Phosphorylated proteins were separated by SDS ± PAGE and electrotransferred to nitrocellulose membrane (Hybond C-extra, Amersham). Tryptic digestion was performed essentially according to Mori et al. (1993) . Immunoprecipitation of tryptic peptides, with antibodies covalently coupled to Protein A-Sepharose, was performed according to Hansen et al. (1996) . After elution with 1% diethylamine, the peptides were covalently coupled to Sequelon AA membranes according to the manufacturer's description and subjected to Edman degradation in an Applied Biosystems Gas Phase Sequenator (Model 477A), as described by Blume-Jensen et al. (1995) .
Mitogenic assay
PAE cells expressing equal levels of PDGF a-and breceptors were seeded in 12-well plates and grown for 24 h. While cells were still subcon¯uent, the medium was changed to starvation medium (Ham's F-12, 0.3% FBS). After 24 h of starvation, 0.2 mCi [ 3 H]thymidine/ml (Amersham) and PDGF (0 ± 25 ng/ml) or 10% FBS were added and incubation continued for 20 h. Macromolecules were then precipitated using 5% trichloracetic acid (TCA), samples were washed three times in ice-cold H 2 O and dissolved in 1 M NaOH, followed by neutralization with 2 M HCl. [ 3 H]radioactivity was measured in a liquid scintillation counter.
MAP kinase assay
Cells were starved overnight in 0.3% FCS and then stimulated with 100 ng/ml of PDGF for indicated time periods at 378C. Cells were lysed in 1% Triton X-100, 0.5% sodium deoxycholate, 20 mM HEPES, pH 8.0, 10 mg/ ml leupeptin (Boehringer Mannheim), 1% aprotinin, 1 mM PMSF, 20 mM Na 4 P 2 O 7 , 200 mM Na 3 VO 4 , 10 mM EGTA, 5 mM MgCl 2 , 1 mM DTT and lysates incubated with a rabbit antiserum against MAP kinase for 2 h at 48C, as described above. The immunoprecipitated samples were washed three times with the lysis buer, once with 20 mM HEPES, pH 8.0, and twice with a kinase buer (20 mM HEPES, pH 8.0, 20 mM MgCl 2 , 2 mM MnCl 2 , 1 mM DTT). The samples were subjected to an in vitro kinase assay for 15 min at 308C in 40 ml kinase buer supplemented with 5 mCi [g-32 P]ATP and 10 mg myelin basic protein (MBP; GIBCO BRL). Reactions were stopped by addition of SDS-sample buer, samples were boiled for 5 min and separated on a 15% SDS-polyacrylamide gel. Quantification of radioactivity incorporation into protein bands corresponding to MBP was done using a Bioimage analyzer BAS 2000 (Fuji).
Detection of guanine nucleotides bound to Ras
Ras bound guanine nucleotides was measured at dierent time points after stimulation with either PDGF-AA, PDGF-BB or PDGF-AB, in cells starved overnight in Ham's F-12, 0.3% FBS, essentially according to Burgering et al. (1991) . Guanine nucleotides were quanti®ed using a Fuji BAS 2000 Bioimage Analyzer.
